Based on the data, I would recommend a SELL. Here's why:

* The trailing PE of 59.21 is already elevated, and the forward PE of 80.26 suggests that the market is pricing in high growth expectations. However, the revenue growth and earnings growth are both negative, which doesn't justify the high PE multiples.
* The ROE of 18.79% is decent but not exceptional, considering the industry and market conditions.
* The debt-to-equity ratio of 11.42% is a concern, as it may increase the risk of the company and put pressure on its profitability in the near term.

Given these factors, I believe that the stock is overvalued and due for a correction. Hence, I would suggest a SELL.